Day: June 5, 2020
TULSA, June 05, 2020 (GLOBE NEWSWIRE) — Mid-Con Energy Partners, LP (NASDAQ: MCEP) (“Mid-Con” or the “Partnership”) has entered into a strategic recapitalization transaction with its preferred equity holders, providing for the conversion of all Series A and B Preferred Units into common units at an average conversion price of $3.12/unit.In connection with the recapitalization, ownership of the Partnership’s general partner, Mid-Con GP, LLC (the “General Partner”), has been transferred to the Partnership, resulting in strengthened corporate governance, and a new Board of Directors has been elected by written consent of the holders of a majority of the common unitholders.The Partnership also announced today the close of the spring redetermination of the borrowing base under its senior secured revolving credit facility (the “Credit...
Lord Global Corporation CEO details the company’s vision for its significant revenue and earnings growth for 2020 beyond
Written by Customer Service on . Posted in Public Companies.
NEW YORK, June 05, 2020 (GLOBE NEWSWIRE) — The following is a letter to shareholders from Lord Global Corporation’s (OTC: LRDG) CEO:Dear fellow shareholders, I would like to take this opportunity to update all shareholders on our vision for Lord Global Corporation. The company intends to focus on the business development of its 27Health Inc. subsidiary. 27Health Inc. is dedicated to financing and marketing innovative, healthcare related products that are and will benefit from the permanent changes caused by the COVID-19 pandemic. It is our feeling that this crisis has accelerated the market share of direct to consumer healthcare products and services. Prior to the crisis, the direct to consumer cloud based market was among the fastest growing, subsequent to this crisis, we believe that 10 years worth of market share has been condensed...
Avenue Therapeutics Announces Publications in Peer-Reviewed Journals
Written by Customer Service on . Posted in Public Companies.
NEW YORK, June 05, 2020 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today announced the following publications in peer-reviewed journals.The publication titled “Intravenous Tramadol is Effective in the Management of Postoperative Pain Following Abdominoplasty: A Three-Arm Randomized Placebo- and Active-Controlled Trial” has been published in Drugs in R&D and can be accessed here.The objective of this Phase 3 study was to evaluate the safety, tolerability and efficacy of IV tramadol 50 mg versus placebo in patients following abdominoplasty surgery, a soft-tissue surgical model. The study included an active comparator arm, IV morphine 4mg. While the study was not powered to provide statistical comparison of the...
XpresSpa Group Signs Contract with HyperPointe™ for Airport-based COVID-19 Screening and Testing
Written by Customer Service on . Posted in Public Companies.
NEW YORK, June 05, 2020 (GLOBE NEWSWIRE) — XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced that it has partnered with HyperPointe in connection with, XpresCheck, its newly formed business unit that will provide COVID-19 screening and testing in U.S. airports.Ezra T. Ernst, HyperPointe CEO, said, “We are extremely proud and excited to be working with XpresCheck in combatting this global pandemic and doing our part to help get the country back to normal. Airports serve as the gateway to our country, and ensuring their safety is a key step in getting us back to business as usual.”HyperPointe is providing a full range of support that extends far beyond marketing, according to Mr. Ernst.“We like to think of ourselves as co-pilots in helping XpresCheck launch this exciting...
Front Yard Residential Corporation Provides Operating Update
Written by Customer Service on . Posted in Public Companies.
CHRISTIANSTED, U.S. Virgin Islands, June 05, 2020 (GLOBE NEWSWIRE) — Front Yard Residential Corporation (“Front Yard” or the “Company”) (NYSE: RESI) today reported the following operating metrics for April and May 2020:May collections at 30 days were 99% of the trailing 12-month historical average and April collections at 60 days were slightly ahead of the trailing 12-month historical average.Stabilized Rental leased percentage as of May 31, 2020 continued its positive trend at 98.2%, compared with 97.7% at April 30, 2020 and 97.0% at March 31, 2020.1Stabilized Rental April average occupied days were 95.5% compared to 93.5% a year ago, and May average occupied days were 96.1% compared to 92.7% a year ago.1Blended rent growth for both April and May was 3.9%.“Our primary concern has been and continues to be our residents, our employees...
Harsco to Participate in the Stifel 2020 Virtual Cross Sector Insight Conference
Written by Customer Service on . Posted in Public Companies.
CAMP HILL, Pa., June 05, 2020 (GLOBE NEWSWIRE) — Harsco Corporation (NYSE: HSC) announced today that Company management will participate in the Stifel 2020 Virtual Cross Sector Insight Conference on Wednesday, June 10. The Company will be represented by Chairman and CEO Nick Grasberger and Investor Relations Vice President Dave Martin. Updated presentation materials are available on the Company’s website at https://investors.harsco.com/.About Harsco Corporation Harsco Corporation is a global market leader providing environmental solutions for industrial and specialty waste streams and innovative technologies for the rail sector. Based in Camp Hill, PA, the 13,000-employee company operates in more than 30 countries. Harsco’s common stock is a component of the S&P SmallCap 600 Index and the Russell 2000 Index. Additional information...
Arcturus Therapeutics Announces First Healthy Volunteer Dosed in Phase 1 Study of ARCT-810 for Ornithine Transcarbamylase (OTC) Deficiency
Written by Customer Service on . Posted in Public Companies.
SAN DIEGO, June 05, 2020 (GLOBE NEWSWIRE) — Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, today announced that it has dosed the first healthy volunteer in a Phase 1 study with ARCT-810, the Company’s messenger RNA (mRNA)-based therapeutic candidate for Ornithine Transcarbamylase (OTC) deficiency.“We are excited to advance ARCT-810, a highly promising mRNA-based therapeutic candidate for OTC deficiency, into a Phase 1 study. This important milestone marks Arcturus’ transition into a clinical stage biopharmaceutical company,” said Steve Hughes, M.D., Chief Development Officer of Arcturus. “ARCT-810 is supported by compelling preclinical...
AgraFlora Takes Steps to Obtain Additional EU-GMP Quality Cannabis for German Distribution
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, June 05, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that on June 3, 2020, its wholly owned subsidiary Farmako GmbH (“Farmako”) has entered into a binding supply term sheet (the “Term Sheet”) with ZenPharm Ltd (“ZenPharm”), a subsidiary of Zenabis Global Inc. (“Zenabis”) The Term Sheet serves as the basis to enter into a supply agreement which is expected to be completed in the coming weeks.Under the conditions of the Term Sheet, ZenPharm will supply EU-GMP quality medical cannabis flower cultivated by Zenabis to Farmako for distribution to medical cannabis patients in Germany. The agreement is intended to facilitate the distribution of 1,500 kilograms of cannabis flower by Farmako...
AgraFlora prend des mesures afin d’obtenir plus de cannabis de qualité EU-GMP pour être distribué en Allemagne
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, Colombie-Britannique, 05 juin 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE : AGRA) (Frankfurt: PU31) (OTCPK : AGFAF) a le plaisir d’annoncer que le 3 juin 2020, sa filiale en propriété exclusive Farmako GmbH (« Farmako ») a conclu un accord d’approvisionnement contraignant (l’« Accord contraignant ») avec ZenPharm Ltd (« ZenPharm »), une filiale de Zenabis Global Inc (« Zenabis »). L’accord contraignant jette les bases à la conclusion d’un accord d’approvisionnement définitif qui devrait être finalisé dans les semaines à venir.Selon les termes de l’accord contraignant, ZenPharm fournira à Farmako des fleurs de cannabis médical de qualité EU-GMP cultivée par Zenabis pour être distribuées aux patients faisant usage de cannabis médical en Allemagne. L’accord vise à...
Sabina Gold & Silver Announces AGM Voting Results
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, June 05, 2020 (GLOBE NEWSWIRE) — Sabina Gold & Silver Corp. (TSX:SBB, OTCQX: SGSVF) (Sabina or the “Company”), in accordance with Toronto Stock Exchange requirements, is pleased to announce the voting results for election of its Board of Directors at its hybrid Annual General and Special Meeting of Shareholders held on June 4, 2020 in Vancouver, British Columbia. The director nominees as listed in the Management Information Circular dated April 22, 2020 were elected as directors of the Company at the meeting to serve until the next Annual General Meeting. In addition, the appointment of auditors as well as the Company’s adoption of new Articles were approved. The results are as follows:Total Eligible Votes: 298,213,292, Total Voted: 185,859,227 Total Voted %: 62.32%“On behalf of the Board of Directors,...